Loading clinical trials...
Loading clinical trials...
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Conditions
Interventions
cyclophosphamide
goserelin acetate
Locations
34
Australia
Mater Hospital - North Sydney
North Sydney, New South Wales, Australia
Royal North Shore Hospital
St Leonards, New South Wales, Australia
Newcastle Mater Misericordiae Hospital
Waratah, New South Wales, Australia
Royal Adelaide Hospital Cancer Centre
Adelaide, South Australia, Australia
Flinders Medical Centre
Bedford Park, South Australia, Australia
Royal Hobart Hospital
Hobart, Tasmania, Australia
Start Date
October 1, 2003
Primary Completion Date
January 1, 2014
Completion Date
September 1, 2016
Last Updated
December 30, 2019
NCT04550494
NCT05372640
NCT05673200
NCT04704661
NCT05245812
NCT07483307
Lead Sponsor
SWOG Cancer Research Network
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions